SPTX peer analysis
Seaport Therapeutics (SPTX) against its competitors: price, today's move, 1-year return and market value side by side.
SPTX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| CTNM Contineum Therapeutics | $9.23 | -3.30% | -17.17% | $362.62M |
| GHRS GH Research | $18.26 | -0.05% | 29.50% | $1.25B |
| KTTA Pasithea Therapeutics | $0.43 | -13.14% | -40.51% | $14.51M |
| LBRX LB Pharmaceuticals | $40.11 | -0.47% | 135.25% | $1.30B |
| MPLT MapLight Therapeutics | $6.64 | 1.07% | -51.50% | $373.22M |
| NMRA Neumora Therapeutics | $0.33 | -9.47% | -87.08% | $62.85M |
| QNTM Quantum Biopharma | $1.59 | 10.42% | -77.95% | $10.22M |
| RAPP Rapport Therapeutics | $23.47 | -1.22% | -6.53% | $1.13B |
| SER Serina Therapeutics | $1.36 | -3.87% | -64.24% | $36.27M |
| VNDA Vanda Pharmaceuticals | $3.75 | -1.44% | -14.66% | $227.06M |
| SPTX Seaport Therapeutics | $18.33 | 0.88% | – | $981.21M |
- SPTX's peers: CTNM (Contineum Therapeutics), GHRS (GH Research), KTTA (Pasithea Therapeutics), LBRX (LB Pharmaceuticals), MPLT (MapLight Therapeutics), NMRA (Neumora Therapeutics), QNTM (Quantum Biopharma), RAPP (Rapport Therapeutics).
Updated 2026-11-19 00:45 UTC